Respiratory Disease
Showing 1 - 25 of >10,000
COPD Exacerbation Acute, COPD With Acute Lower Respiratory Infection, Rhinovirus Trial (Vapendavir, Placebo)
Not yet recruiting
- COPD Exacerbation Acute
- +35 more
- Vapendavir
- Placebo
- (no location specified)
Nov 20, 2023
Chronic Lung Disease Trial in New Taipei City (Standard pulmonnary rehabilitation, Nutritional supplementation intervention)
Recruiting
- Chronic Lung Disease
- Standard pulmonnary rehabilitation
- Nutritional supplementation intervention
-
New Taipei City, TaiwanFu Jen Catholic University Hospital, Fu Jen Catholic University
Oct 29, 2023
Tele-rehabilitation in Chronic Respiratory Disease:Observational
Recruiting
- Chronic Respiratory Disease
- pulmonary rehabilitation
-
Toronto, Ontario, CanadaWest Park Healthcare Centre
Apr 6, 2023
Set for Head, Neck and Respiratory Disease in
Completed
- Mucopolysaccharidosis Type II
-
Manchester, Lancashire, United KingdomManchester University NHS Foundation Trust
Aug 31, 2023
ResAppDx v2.0 asAid to Diagnose Respiratory Disease in
Not yet recruiting
- Asthma Exacerbation
- +3 more
- ResAppDx v.20
-
London, United Kingdom
- +2 more
Nov 26, 2023
Respiratory Disease, Allergic Diseases and/or Mast Cell
Not yet recruiting
- Allergic Diseases
- +2 more
-
Toulouse, FranceLaurent GUILLEMINAULT
Sep 7, 2023
AERD - Aspirin Exacerbated Respiratory Disease Trial in Kraków (Aspirin 300 Mg Oral Tablet, Placebo)
Recruiting
- AERD - Aspirin Exacerbated Respiratory Disease
- Aspirin 300 Mg Oral Tablet
- Placebo
-
Kraków, PolandUniversity Hospital, Pulmunology Clinic
Apr 4, 2023
COPD Trial in Guangzhou (compound ipratropium bromide solution (3mg salbutamol and 500µg ipratropium, Boehringer Ingelheim
Recruiting
- Chronic Obstructive Pulmonary Disease
- compound ipratropium bromide solution (3mg salbutamol and 500μg ipratropium, Boehringer Ingelheim Limited, Germany)
-
Guangzhou, Guangdong, China1State Key Laboratory of Respiratory Disease, National clinical
Mar 15, 2023
ResAppDx v2.0 asAid to Diagnose Respiratory Disease in
Not yet recruiting
- Croup
- +5 more
- ResAppDx v.20
-
Birmingham, United Kingdom
- +4 more
Nov 26, 2023
CAPTURE Case Finding Tool for Obstructive Respiratory Disease
Not yet recruiting
- Lung Diseases
- +2 more
- CAPTURE tool
- (no location specified)
Jan 13, 2023
Pulmonary Fibrosis, Pulmonary Disease, Chronic Obstructive Trial in Québec, Lomme (Functional capacity tests)
Not yet recruiting
- Pulmonary Fibrosis
- Pulmonary Disease, Chronic Obstructive
- Functional capacity tests
-
Québec, Canada
- +1 more
Nov 6, 2023
Chronic Respiratory Disease Based on Metabolomics:Prospective
Not yet recruiting
- Chronic Obstructive Pulmonary Disease
- Bronchiectasis
- metabonomics
- (no location specified)
Jan 11, 2023
Chronic Pulmonary Disease Trial in New Taipei City (Eccentric bike, Helmet ventilation)
Not yet recruiting
- Chronic Pulmonary Disease
- Eccentric bike
- Helmet ventilation
-
New Taipei City, TaiwanFu Jen Catholic University Hospital, Fu Jen Catholic University
Feb 27, 2023
Occupational Exposure Trial in Aurora (Exercise training)
Recruiting
- Occupational Exposure
- Exercise training
-
Aurora, Colorado
- +1 more
May 8, 2023
Biomarkers in Lung Cancer
Not yet recruiting
- Lung Nodule
- Lung Cancer
- Extra blood sampling, Non-invasive or leftover samples or medical waste
-
Toulouse, FranceLarrey Hospital
Sep 19, 2023
Nasal Polyps, Asthma, Aspirin-Induced, Aspirin-exacerbated Respiratory Disease Trial in Boston (Ifetroban, Placebo)
Active, not recruiting
- Nasal Polyps
- +3 more
- Ifetroban
- Placebo
-
Boston, MassachusettsAsthma Research Center, Brigham and Women's Hospital
Oct 7, 2022
Neutrophil Extracellular Traps and Damage-associated Molecular
Recruiting
- Chronic Respiratory Disease
-
Guangzhou, Guangdong, ChinaHaijin Zhao
Oct 7, 2022
Is Gait Speed and Sarcopenia Prognostic in Chronic Respiratory
Completed
- Chronic Obstructive Pulmonary Disease and Allied Conditions
-
Harefield, Middlesex, United KingdomHarefield hospital
Oct 30, 2022
Prematurity, Respiratory Disease, Ventilator Lung; Newborn Trial (Caffeine citrate, Placebo)
Not yet recruiting
- Prematurity
- +2 more
- Caffeine citrate
- Placebo
- (no location specified)
Sep 3, 2023
Nasal Polyps, Asthma, Aspirin-Induced, Aspirin-Exacerbated Respiratory Disease Trial in Boston (Dupilumab, Placebo)
Not yet recruiting
- Nasal Polyps
- +3 more
- Dupilumab
- Placebo
-
Boston, MassachusettsBrigham and Women's Hospital
Oct 7, 2022
Respiratory Disease, Muscle Weakness, Acquired Brain Injury Trial (Inspiratory muscle training, Expiratory muscle training)
Not yet recruiting
- Respiratory Disease
- +4 more
- Inspiratory muscle training
- Expiratory muscle training
- (no location specified)
Sep 30, 2023
Chronic Respiratory Disease Trial in Toronto (AutoO2, FixedO2)
Recruiting
- Chronic Respiratory Disease
- AutoO2
- FixedO2
-
Toronto, Ontario, CanadaWest Park Healthcare Centre
Nov 22, 2023
Chronic Respiratory Disease Trial in Hauteville-Lompnes (Adapted information arm, Neutral information arm)
Recruiting
- Chronic Respiratory Disease
- Adapted information arm
- Neutral information arm
-
Hauteville-Lompnes, France
- +1 more
Jan 16, 2023
QIAstat-Dx® Respiratory Panel Plus Clinical Performance Study
Not yet recruiting
- Respiratory Disease
- QIAstat-Dx® Respiratory Panel Plus (RPP)
- (no location specified)
Feb 16, 2023